Update: 10.05.2023
Last week: 17 week 2023 (24.04.2023 - 30.04.2023)
Last full month: April 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 80 672 | 4.4% | 2.6% | 0.1 | 20 183 134 | 3.5% | 3.0% | 0.1 | -0.5% |
| MoM | 341 256 | -21.7% | 2.6% | -0.2 | 86 209 752 | -23.4% | 3.0% | -0.2 | -17.1% |
| YTD | 1 688 534 | -65.6% | 2.7% | -3.4 | 445 650 290 | -53.9% | 3.3% | -2.6 | -23.0% |
| MAT | 6 625 692 | -56.5% | 3.5% | -3.2 | 1 498 598 368 | -45.8% | 3.7% | -2.5 | -17.2% |
| DEXALGIN | |||||||||
| WoW | 16 879 | -2.0% | 0.4% | 0 | 8 638 011 | -3.3% | 1.1% | 0 | -1.4% |
| MoM | 73 474 | -1.7% | 0.4% | 0 | 37 876 372 | -4.2% | 1.1% | 0 | -4.7% |
| YTD | 291 494 | -62.6% | 0.4% | -0.4 | 154 488 345 | -51.7% | 1.2% | -1 | -16.3% |
| MAT | 1 096 817 | -46.8% | 0.4% | -0.3 | 521 404 590 | -35.7% | 1.3% | -0.7 | -12.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 56 538 | -5.1% | 39.9% | -0.7 | 33 787 179 | -6.3% | 46.6% | -1.6 | -3.4% |
| MoM | 256 248 | -1.5% | 40.7% | 0.1 | 155 130 453 | -4.3% | 48.2% | -1.6 | -1.8% |
| YTD | 938 698 | -52.9% | 39.9% | -19.5 | 588 487 782 | -41.1% | 49.2% | -15.7 | -29.9% |
| MAT | 3 229 272 | -41.4% | 45.9% | -16.6 | 1 797 228 954 | -32.2% | 52.9% | -15 | -20.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 19 899 | -2.9% | 29.9% | 0.1 | 14 709 159 | -3.4% | 45.3% | 0 | -3.2% |
| MoM | 91 037 | -5.8% | 30.2% | 0.8 | 67 902 849 | -8.4% | 45.8% | 0.1 | -8.1% |
| YTD | 354 996 | -38.7% | 29.6% | -10 | 272 865 557 | -22.8% | 46.2% | -7.2 | -18.1% |
| MAT | 1 201 769 | -27.4% | 33.4% | -6.8 | 825 020 713 | -16.4% | 47.8% | -6.6 | -12.6% |
| FASTUM | |||||||||
| WoW | 15 011 | -0.1% | 0.8% | 0 | 9 140 261 | -0.9% | 2.1% | 0.1 | -2.9% |
| MoM | 65 497 | -1.5% | 0.8% | 0 | 40 044 031 | -0.1% | 2.1% | 0 | 1.1% |
| YTD | 251 452 | -44.4% | 0.8% | -0.5 | 153 212 975 | -32.5% | 2.3% | -0.6 | -10.2% |
| MAT | 839 804 | -37.4% | 0.9% | -0.5 | 472 555 956 | -26.2% | 2.3% | -0.7 | -5.2% |
| IODOMARIN | |||||||||
| WoW | 69 665 | -3.6% | 23.0% | -0.1 | 12 667 365 | -3.7% | 9.4% | -0.1 | -3.1% |
| MoM | 319 397 | -8.6% | 23.5% | -0.2 | 58 249 242 | -10.0% | 9.7% | -0.1 | -7.8% |
| YTD | 1 181 861 | 8.8% | 22.7% | 4.4 | 218 626 468 | 1.7% | 9.2% | 1.1 | -12.6% |
| MAT | 3 388 870 | 1.5% | 22.2% | 1.6 | 643 652 600 | 1.4% | 9.5% | 0.3 | -5.7% |
| LIOTON | |||||||||
| WoW | 19 268 | -1.3% | 1.7% | 0 | 24 148 644 | -2.4% | 4.3% | 0 | -2.7% |
| MoM | 85 686 | 10.7% | 1.8% | 0.1 | 108 632 721 | 11.1% | 4.5% | 0.3 | 1.5% |
| YTD | 286 225 | -47.3% | 1.7% | -0.9 | 360 115 644 | -33.3% | 4.3% | -0.8 | -19.5% |
| MAT | 994 278 | -42.1% | 1.9% | -0.9 | 1 127 416 018 | -26.5% | 4.3% | -1.3 | -14.9% |
| MEZYM | |||||||||
| WoW | 213 752 | -12.9% | 16.9% | -1.7 | 33 380 878 | -12.4% | 11.9% | -1.1 | -4.3% |
| MoM | 964 014 | -1.1% | 17.9% | -0.6 | 150 529 625 | -2.7% | 12.2% | -0.5 | 2.4% |
| YTD | 3 701 730 | -56.0% | 18.8% | -11.7 | 581 146 451 | -54.8% | 12.8% | -9.1 | -28.5% |
| MAT | 12 637 096 | -44.5% | 20.9% | -9.5 | 1 938 858 027 | -41.2% | 14.6% | -7.7 | -19.4% |
| MIG 400 | |||||||||
| WoW | 133 562 | -9.2% | 2.8% | -0.2 | 17 368 422 | -6.8% | 2.2% | -0.1 | -1.4% |
| MoM | 589 337 | 9.2% | 2.8% | 0.4 | 74 310 409 | 16.5% | 2.1% | 0.3 | -4.7% |
| YTD | 1 995 629 | -40.6% | 2.4% | -1 | 245 242 682 | -37.5% | 1.9% | -0.8 | -16.3% |
| MAT | 7 029 825 | -33.5% | 2.8% | -0.9 | 846 819 264 | -29.6% | 2.2% | -0.8 | -12.1% |
| PROSTAMOL | |||||||||
| WoW | 19 788 | -4.0% | 12.6% | -0.1 | 28 834 967 | -4.0% | 13.7% | 0 | -3.4% |
| MoM | 89 337 | -8.0% | 12.6% | -0.1 | 130 642 676 | -10.0% | 13.6% | -0.4 | -7.3% |
| YTD | 356 256 | -51.3% | 13.0% | -8.8 | 532 163 597 | -48.3% | 14.4% | -8.7 | -18.4% |
| MAT | 1 170 808 | -45.0% | 14.9% | -8.8 | 1 666 815 831 | -40.7% | 15.9% | -9.3 | -12.4% |
| RESPERO MYRTOL | |||||||||
| WoW | 19 940 | -3.4% | 6.9% | 0.1 | 10 490 617 | -4.3% | 7.0% | 0 | -4.6% |
| MoM | 89 099 | -12.6% | 6.8% | 0 | 47 458 842 | -16.6% | 7.1% | -0.6 | -12.4% |
| YTD | 384 477 | -34.1% | 7.0% | -2.4 | 215 494 395 | -20.3% | 7.9% | -1.3 | -11.6% |
| MAT | 1 102 274 | -7.3% | 7.4% | -0.2 | 568 660 695 | 4.0% | 8.0% | 0.4 | -5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 1 688 534 | -65.6% | 2.7% | -3.4 | 445 650 290 | -53.9% | 3.3% | -2.6 | -23.0% |
| DEXALGIN | 291 494 | -62.6% | 0.4% | -0.4 | 154 488 345 | -51.7% | 1.2% | -1 | -16.3% |
| ESPUMISAN (ADULTS) | 938 698 | -52.9% | 39.9% | -19.5 | 588 487 782 | -41.1% | 49.2% | -15.7 | -29.9% |
| ESPUMISAN BABY | 354 996 | -38.7% | 29.6% | -10 | 272 865 557 | -22.8% | 46.2% | -7.2 | -18.1% |
| FASTUM | 251 452 | -44.4% | 0.8% | -0.5 | 153 212 975 | -32.5% | 2.3% | -0.6 | -10.2% |
| IODOMARIN | 1 181 861 | 8.8% | 22.7% | 4.4 | 218 626 468 | 1.7% | 9.2% | 1.1 | -12.6% |
| LIOTON | 286 225 | -47.3% | 1.7% | -0.9 | 360 115 644 | -33.3% | 4.3% | -0.8 | -19.5% |
| MEZYM | 3 701 730 | -56.0% | 18.8% | -11.7 | 581 146 451 | -54.8% | 12.8% | -9.1 | -28.5% |
| MIG 400 | 1 995 629 | -40.6% | 2.4% | -1 | 245 242 682 | -37.5% | 1.9% | -0.8 | -16.3% |
| PROSTAMOL | 356 256 | -51.3% | 13.0% | -8.8 | 532 163 597 | -48.3% | 14.4% | -8.7 | -18.4% |
| RESPERO MYRTOL | 384 477 | -34.1% | 7.0% | -2.4 | 215 494 395 | -20.3% | 7.9% | -1.3 | -11.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 625 692 | -56.5% | 3.5% | -3.2 | 1 498 598 368 | -45.8% | 3.7% | -2.5 | -17.2% |
| DEXALGIN | 1 096 817 | -46.8% | 0.4% | -0.3 | 521 404 590 | -35.7% | 1.3% | -0.7 | -12.1% |
| ESPUMISAN (ADULTS) | 3 229 272 | -41.4% | 45.9% | -16.6 | 1 797 228 954 | -32.2% | 52.9% | -15 | -20.1% |
| ESPUMISAN BABY | 1 201 769 | -27.4% | 33.4% | -6.8 | 825 020 713 | -16.4% | 47.8% | -6.6 | -12.6% |
| FASTUM | 839 804 | -37.4% | 0.9% | -0.5 | 472 555 956 | -26.2% | 2.3% | -0.7 | -5.2% |
| IODOMARIN | 3 388 870 | 1.5% | 22.2% | 1.6 | 643 652 600 | 1.4% | 9.5% | 0.3 | -5.7% |
| LIOTON | 994 278 | -42.1% | 1.9% | -0.9 | 1 127 416 018 | -26.5% | 4.3% | -1.3 | -14.9% |
| MEZYM | 12 637 096 | -44.5% | 20.9% | -9.5 | 1 938 858 027 | -41.2% | 14.6% | -7.7 | -19.4% |
| MIG 400 | 7 029 825 | -33.5% | 2.8% | -0.9 | 846 819 264 | -29.6% | 2.2% | -0.8 | -12.1% |
| PROSTAMOL | 1 170 808 | -45.0% | 14.9% | -8.8 | 1 666 815 831 | -40.7% | 15.9% | -9.3 | -12.4% |
| RESPERO MYRTOL | 1 102 274 | -7.3% | 7.4% | -0.2 | 568 660 695 | 4.0% | 8.0% | 0.4 | -5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 80 672 | 4.4% | 2.6% | 0.1 | 20 183 134 | 3.5% | 3.0% | 0.1 | -0.5% |
| DEXALGIN | 16 879 | -2.0% | 0.4% | 0 | 8 638 011 | -3.3% | 1.1% | 0 | -1.4% |
| ESPUMISAN (ADULTS) | 56 538 | -5.1% | 39.9% | -0.7 | 33 787 179 | -6.3% | 46.6% | -1.6 | -3.4% |
| ESPUMISAN BABY | 19 899 | -2.9% | 29.9% | 0.1 | 14 709 159 | -3.4% | 45.3% | 0 | -3.2% |
| FASTUM | 15 011 | -0.1% | 0.8% | 0 | 9 140 261 | -0.9% | 2.1% | 0.1 | -2.9% |
| IODOMARIN | 69 665 | -3.6% | 23.0% | -0.1 | 12 667 365 | -3.7% | 9.4% | -0.1 | -3.1% |
| LIOTON | 19 268 | -1.3% | 1.7% | 0 | 24 148 644 | -2.4% | 4.3% | 0 | -2.7% |
| MEZYM | 213 752 | -12.9% | 16.9% | -1.7 | 33 380 878 | -12.4% | 11.9% | -1.1 | -4.3% |
| MIG 400 | 133 562 | -9.2% | 2.8% | -0.2 | 17 368 422 | -6.8% | 2.2% | -0.1 | -1.4% |
| PROSTAMOL | 19 788 | -4.0% | 12.6% | -0.1 | 28 834 967 | -4.0% | 13.7% | 0 | -3.4% |
| RESPERO MYRTOL | 19 940 | -3.4% | 6.9% | 0.1 | 10 490 617 | -4.3% | 7.0% | 0 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 341 256 | -21.7% | 2.6% | -0.2 | 86 209 752 | -23.4% | 3.0% | -0.2 | -17.1% |
| DEXALGIN | 73 474 | -1.7% | 0.4% | 0 | 37 876 372 | -4.2% | 1.1% | 0 | -4.7% |
| ESPUMISAN (ADULTS) | 256 248 | -1.5% | 40.7% | 0.1 | 155 130 453 | -4.3% | 48.2% | -1.6 | -1.8% |
| ESPUMISAN BABY | 91 037 | -5.8% | 30.2% | 0.8 | 67 902 849 | -8.4% | 45.8% | 0.1 | -8.1% |
| FASTUM | 65 497 | -1.5% | 0.8% | 0 | 40 044 031 | -0.1% | 2.1% | 0 | 1.1% |
| IODOMARIN | 319 397 | -8.6% | 23.5% | -0.2 | 58 249 242 | -10.0% | 9.7% | -0.1 | -7.8% |
| LIOTON | 85 686 | 10.7% | 1.8% | 0.1 | 108 632 721 | 11.1% | 4.5% | 0.3 | 1.5% |
| MEZYM | 964 014 | -1.1% | 17.9% | -0.6 | 150 529 625 | -2.7% | 12.2% | -0.5 | 2.4% |
| MIG 400 | 589 337 | 9.2% | 2.8% | 0.4 | 74 310 409 | 16.5% | 2.1% | 0.3 | -4.7% |
| PROSTAMOL | 89 337 | -8.0% | 12.6% | -0.1 | 130 642 676 | -10.0% | 13.6% | -0.4 | -7.3% |
| RESPERO MYRTOL | 89 099 | -12.6% | 6.8% | 0 | 47 458 842 | -16.6% | 7.1% | -0.6 | -12.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs